WebBiotheranostics, Inc. (BTX) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. BTX does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. ... Hologic, Biotheranostics, Breast Cancer Index ... WebMar 30, 2024 · The expanded lab will be the new headquarters for Biotheranostics, a San Diego-based company acquired by Hologic in 2024 for $230 million. The new lab increases the Biothernostic’s testing capacity for its Breast Cancer Index and CancerTYPE ID tests by four times and will feature a new R&D space to explore additional tests.
Terry Neofitos - Northeast Regional Manager, …
WebJan 5, 2024 · Biotheranostics generated approximately $33 million of revenue in calendar 2024. The acquisition is expected to be slightly dilutive to Hologic’s non-GAAP earnings per share in fiscal 2024, break-even in 2024, and accretive thereafter. The acquisition is expected to close in February of 2024, subject to antitrust clearance and other customary ... WebJan 5, 2024 · On January 5, 2024, Hologic acquired life science company Biotheranostics for 230M USD Acquisition Highlights. This is Hologic’s 2nd transaction in the Life Science sector. This is Hologic’s 7th largest (disclosed) transaction. This is Hologic’s 15th transaction in the United States. This is Hologic’s 4th transaction in California. dandy outfit
Hologic to acquire Mobidiag in $795M deal - MassDevice
WebLonger term, while Biotheranostics currently markets its products only in the US, Hologic plans to leverage its own sales and marketing teams to promote them internationally. Also in the long run, Hologic may configure Biotheranostics' tests to run on Hologic's Panther Fusion platform, Thornal added. WebHologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. ... In January 2024, the company announced it would acquire Biotheranostics and its breast and metastatic cancer test portfolio for $230 Million and SOMATEX for $64 Million. WebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: … birmingham cvb staff